Open Access10.1002/ANBR.202100109
Lipid Nanoparticles for Drug Delivery
Letao Xu,Xing Wang,Yun Liu,Guangze Yang,Robert J. Falconer,Chun-Xia Zhao,Chun-Xia Zhao +6 more
- 25 Nov 2021
- pp 2100109
258
About: The article was published on 25 Nov 2021. and is currently open access. The article focuses on the topics: Solid lipid nanoparticle & Drug delivery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer
Zhaowu Zeng,Xianglong Zeng,Xinyi Li,Yuxin Feng,Yue Kan,Xingyan Liu,Yiying Zeng +6 more
TL;DR: The pharmacodynamic results reveal that TGFβ1 siRNA LNPs modified with CE1.5, CE2.5, or TPGS2.5 can be used to effectively treat paclitaxel-resistant lung adenocarcinoma.
Nanoparticles as Drug Delivery Vehicles for People with Cystic Fibrosis
Eoin Hourihane,Katherine R. Hixon +1 more
TL;DR: This review explores the use of nanoparticles as inhalable drug delivery vehicles for cystic fibrosis treatment, discussing material classes (metals, polymers, lipids) and their potential benefits, as well as FDA-approved nanoparticles for CF-related conditions.
Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier
Laura Fritzen,Katharina Wienken,Lelia Wagner,Magdalena Kurtyka,Katharina Vogel,Jakob Körbelin,Sascha Weggen,Gert Fricker,Claus U. Pietrzik +8 more
TL;DR: Researchers developed a truncated mini LRP1 (mLRP1_DIV*) to transport cargo across the blood-brain barrier, demonstrating its ability to deliver therapeutic antibodies and immunoliposomes into the CNS and reduce toxic Aβ42 peptide levels in vitro.
Application of Nanomaterials and Related Drug Delivery Systems in Autophagy
Ling Mei,Kin Liao,Haiyan Chen,Yifan Zhang,Zihan Zhang,Qiangwei Li,Wei Wang +6 more
TL;DR: This review synthesizes the current understanding of the application of nanomaterials or nano drug delivery systems on autophagy and their potential biological functions, suggesting a new avenue for nanomaterial-based autophagy regulation.
Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems
Luis Carlos Morales,Amarnath Praphakar Rajendran,Aysha Ansari,Remant Bahadur Kc,Mohammad Nasrullah,Kitipong Kiti,Panadda Yotsomnuk,Marianna Kulka,Daniel Nisakar Meenakshi Sundaram,Hasan Uludağ +9 more
TL;DR: Biodistribution of therapeutic siRNAs delivered with lipid-substituted PEI-based delivery systems is improved in various organs, including xenograft tumors, with preferential accumulation in the lungs and spleen.
References
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh,Christopher C. Venters,Chao Di,Anna Maria Pinto,Lili Wan,Ihab Younis,Zhiqiang Cai,Chie Arai,Byung Ran So,Jingqi Duan,Gideon Dreyfuss +10 more
TL;DR: An unexpected role for U1 homeostasis (available U1 relative to transcription) in oncogenic and activated cell states is revealed, and U1 is suggested as a potential target for their modulation.
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra,Gitishree Das,Leonardo Fernandes Fraceto,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos,Estefania Vangelie Ramos Campos,Maria del Pilar Rodriguez-Torres,Laura Susana Acosta-Torres,Luis A. Diaz-Torres,Renato Grillo,Mallappa Kumara Swamy,Shivesh Sharma,Solomon Habtemariam,Han-Seung Shin +13 more
TL;DR: An updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs and selective diagnosis through disease marker molecules is presented.
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell,Margaret M. Billingsley,Rebecca M Haley,Marissa E. Wechsler,Nicholas A. Peppas,Robert Langer +5 more
TL;DR: Advances in nanoparticle design that overcome heterogeneous barriers to delivery are discussed, arguing that intelligent nanoparticles design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.
Doxil®--the first FDA-approved nano-drug: lessons learned.
TL;DR: This review summarizes historical and scientific perspectives of Doxil development and lessons learned from its development and 20 years of its use and demonstrates the obligatory need for applying an understanding of the cross talk between physicochemical, nano-technological, and biological principles.
3.9K
Nanocapsule formation by interfacial polymer deposition following solvent displacement
TL;DR: In this paper, an attempt was made to elucidate the mechanisms of formation in terms of interfacial turbulence between two unequilibrated liquid phases involving flow, diffusion and surface tension decrease (Marangoni effect).
2.2K